about
N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3Inhibition of human neutrophil elastase by pentacyclic triterpenesNeutrophil extracellular traps sequester circulating tumor cells and promote metastasis.Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions.Neutrophil elastase inhibitors.Novel therapies for the treatment of inflammatory airway disease.Extracellular proteases as targets for drug developmentAdvances in the management of chronic obstructive pulmonary disease.New anti-inflammatory therapies and targets for asthma and chronic obstructive pulmonary disease.Neutrophil elastase and its therapeutic effect on leukemia cells.Gene therapy for chronic obstructive pulmonary disease: twilight or triumph?Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamidesChemical toxicology: reactive intermediates and their role in pharmacology and toxicology.Neutrophil serine proteases fine-tune the inflammatory responseTreating COPD with PDE 4 inhibitors.Treatment of COPD: a matrix perspective.Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies.Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosisTargeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.Targets of Neutrophil Influx and Weaponry: Therapeutic Opportunities for Chronic Obstructive Airway Disease.The selective MMP-12 inhibitor, AS111793 reduces airway inflammation in mice exposed to cigarette smoke.Dual bronchodilatory and pulmonary anti-inflammatory activity of RO5024118, a novel agonist at vasoactive intestinal peptide VPAC2 receptors.Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation.The effect of essential oil extracted from Nigella sativa (L.) seeds on human neutrophil functions.alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse.Sulfated caffeic acid dehydropolymer attenuates elastase and cigarette smoke extract-induced emphysema in rats: sustained activity and a need of pulmonary delivery.Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.Degradation of elastic fiber and elevated elastase expression in long head of biceps tendinopathy.Anti-Inflammatory Effects of Agrimoniin-Enriched Fractions of Potentilla erecta.Synthesis and biological evaluation of nigranoic acid esters as novel human neutrophil elastase inhibitors.
P2860
Q28272993-ECD816A2-13EA-496A-9B23-884FA81D83D9Q28537837-8036450C-3B62-4FA0-9EC0-AD81D9DA27CEQ30541882-3A078D1C-F3FF-4228-856E-F9FFD683D12AQ30794373-89BA9504-A1FF-4F0D-B65E-F23FC7C0C29EQ34814104-AC7BFDE2-7E70-4BF4-A06F-A4A23A6FB589Q35040779-D4C7D2D3-1847-4A93-B5C3-4F9EEE0CD3A2Q35116202-AD471451-1686-41BD-A6A5-54692E6E294CQ35164693-8B0CF1E4-18DE-4FFD-99F0-C314E537BEE8Q35842492-2D7F054F-4FAD-4228-9624-3CD9794F7795Q35919739-183970A3-A5F1-42E1-BE1E-210F0B40B9EDQ36099456-C21E2B35-94A2-4222-8FD4-44725FB85185Q36376519-969CCFBB-8B18-4000-B632-61F504AADB9CQ36496641-CB9609FB-EAF2-4F28-A0C6-49295CA31AF8Q36662875-75D83836-F6FF-4D57-A07E-EDDD2307F33BQ36737987-B1EF5D8B-54DF-4A4A-ADC1-163A7CF59F9AQ37082594-5228333D-A5B7-4F3E-9F2E-BCA12288C3EEQ37167363-CF8316C7-3B2E-4F2E-A75E-8E8E69E70766Q37332258-C4813884-B97A-40B9-B2E4-01FD8210CF34Q37819431-FFEB2253-9F0B-45AA-8C98-CBEFDD8CCBCAQ37890978-6D9C5329-FCE4-4F7B-89E0-180DBF006C88Q38673045-8A4FFD46-1593-4661-81C9-052E4A17D5B1Q40884802-E6285F3C-BBED-4389-BFBC-14C950209D86Q41121832-0CE0A916-0F29-45DB-A53E-E2EF2FD8C59BQ41898941-0E562C2D-B1F0-4D60-BB39-D5F0FB787BA4Q43280935-C8135EFE-49A8-4FE2-9662-555E152D8D9EQ44399892-3DCA9F0C-9BAB-4CCB-AD36-D5750F0181B5Q44998183-3B97DE3C-93B0-4E74-8E83-92581705767FQ51215263-7C093BEB-83F6-4465-951F-16D8911AE333Q51276907-3999B858-7B65-4499-89DB-AD753240985DQ51693886-40D66906-4A04-457C-9269-9488DD5A30E4Q53347141-FD8D0ED8-EB8B-4D28-83BB-DB45E541D70C
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neutrophil elastase inhibitors as treatment for COPD.
@ast
Neutrophil elastase inhibitors as treatment for COPD.
@en
Neutrophil elastase inhibitors as treatment for COPD.
@nl
type
label
Neutrophil elastase inhibitors as treatment for COPD.
@ast
Neutrophil elastase inhibitors as treatment for COPD.
@en
Neutrophil elastase inhibitors as treatment for COPD.
@nl
prefLabel
Neutrophil elastase inhibitors as treatment for COPD.
@ast
Neutrophil elastase inhibitors as treatment for COPD.
@en
Neutrophil elastase inhibitors as treatment for COPD.
@nl
P2860
P1476
Neutrophil elastase inhibitors as treatment for COPD.
@en
P2093
Hiroyuki Ohbayashi
P2860
P304
P356
10.1517/13543784.11.7.965
P407
P577
2002-07-01T00:00:00Z